CHEMOPH.BO Chemo Pharma (BSE) 23 Feb 2026 After Hours: Bounce to INR144.37
The CHEMOPH.BO stock shows an after-hours oversold bounce setup after a strong intraday recovery to INR 130.85. Volume rose to 766.00 shares versus an average of 513.00, signalling real trading interest. On the BSE in India, Chemo Pharma Laboratories Limited has clear short-term resistance near INR 134.95 and a practical bounce target at INR 144.37. This article unpacks technical triggers, fundamentals, Meyka AI’s model forecast and a structured trade plan for the oversold bounce strategy.
CHEMOPH.BO stock: Technical setup and bounce trigger
Price action shows a day low at INR 115.00 and a day high at INR 134.95. The intraday gap from the open INR 116.00 to the close INR 130.85 created buying interest.
The immediate trade case for an oversold bounce is a reclaim of the intraday midpoint and a break above INR 134.95 with volume above 513.00. A cautious stop should sit below INR 115.00 to limit downside on failed bounces.
CHEMOPH.BO stock: Key fundamentals and valuation
Chemo Pharma Laboratories Limited trades on the BSE in India with a market cap of INR 196,275,000.00 and 1,500,000.00 shares outstanding. Reported EPS is -81.48 and the trailing PE ratio is -1.61, reflecting losses.
Balance-sheet metrics show book value per share INR 87.63 and PB ratio 1.49. Price-to-sales is steep at 57.92, signalling low revenue per market value. These fundamentals shape a higher-risk, event-driven bounce rather than a long-term value story.
CHEMOPH.BO stock: Meyka AI rates and model forecast
Meyka AI rates CHEMOPH.BO with a score out of 100: Score: 66.53 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a quarterly target of INR 144.37 and a yearly target of INR 182.48. Versus the current price INR 130.85, the model implies a near-term upside of 10.33% to INR 144.37 and a 12-month upside of 39.48% to INR 182.48. Forecasts are model-based projections and not guarantees.
CHEMOPH.BO stock: Sector context and catalysts
Chemo Pharma sits in the Healthcare sector on BSE where the average PE is 39.42 and typical sector net margins run higher than this company’s negative margins. Sector trends are modest YTD, so any company-level news or acquisition moves will drive CHEMOPH.BO performance.
Catalysts to watch include acquisition announcements, earnings updates and any clarification on the company’s stated shift toward power and chemicals. The next scheduled earnings announcement date listed is 2025-08-01.
CHEMOPH.BO stock: Risk profile and trade plan
Key risks include negative EPS -81.48, thin average liquidity with Avg Volume 513.00, and elevated price-to-sales ratio 57.92. These amplify downside on weak news.
A disciplined trade plan: target INR 144.37 on initial bounce, partial profit at INR 152.00 (year high), and a stop-loss near INR 113.00 or below the session low INR 115.00. Position size should reflect this stock’s volatility and low float.
CHEMOPH.BO stock: Trading checklist and execution
Confirm volume above 766.00 on the breakout and prefer BSE execution during regular hours for better fills. Monitor 50-day and 200-day averages at INR 119.95 and INR 117.99 respectively for trend context.
Use limit entries and plan exits. Reassess the trade if new fundamentals emerge or if price closes back below INR 115.00 with rising volume.
Final Thoughts
CHEMOPH.BO stock offers a clear oversold-bounce opportunity after the intraday recovery to INR 130.85 and a lift in volume to 766.00. Short-term upside to Meyka AI’s quarterly model target INR 144.37 is realistic at 10.33% if buyers sustain momentum above INR 134.95. The 12-month model target INR 182.48 implies a 39.48% upside from current levels but rests on operational improvements and any acquisition news. Given a negative EPS of -81.48 and thin liquidity, treat this as a tactical trade and size positions conservatively. Meyka AI’s model and grade flag both opportunity and elevated risk. Watch volume, confirmations above intraday resistance, and company updates before increasing exposure. For our real-time trade screen and position tracking, see the Meyka AI stock page for CHEMOPH.BO
FAQs
What is the immediate price target for CHEMOPH.BO stock?
The immediate target is INR 144.37 per Meyka AI’s quarterly model. This implies a 10.33% upside from INR 130.85 and requires a close above INR 134.95 with volume confirmation.
How risky is an oversold bounce in CHEMOPH.BO stock?
Risk is high due to negative EPS -81.48, thin average volume 513.00, and stretched valuation metrics. Use tight sizing, a stop near INR 113.00–115.00, and trade only with confirmed breakout volume.
What longer-term forecast exists for CHEMOPH.BO stock?
Meyka AI’s yearly forecast is INR 182.48, implying 39.48% upside from INR 130.85. Forecasts are model-based projections and not guarantees.
Where can I follow updates for CHEMOPH.BO stock?
Monitor BSE quotes, company releases and the Chemo Pharma website. For model updates and real-time signals check Meyka AI’s CHEMOPH.BO stock page and official filings.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.